KIROMIC Trademark

Trademark Overview


On Thursday, June 30, 2022, a trademark application was filed for KIROMIC with the United States Patent and Trademark Office. The USPTO has given the KIROMIC trademark a serial number of 97484081. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, July 18, 2024. This trademark is owned by Kiromic Biopharma, Inc.. The KIROMIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use
kiromic

General Information


Serial Number97484081
Word MarkKIROMIC
Filing DateThursday, June 30, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, July 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements


Description of MarkThe mark consists of the word KIROMIC and the letter O of the word represents a sun.
Goods and ServicesPharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKiromic Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Party NameKiromic Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Trademark Events


Event DateEvent Description
Monday, July 4, 2022NEW APPLICATION ENTERED
Wednesday, July 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 21, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, October 3, 2022ASSIGNED TO EXAMINER
Wednesday, October 5, 2022NON-FINAL ACTION WRITTEN
Wednesday, October 5, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, July 8, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 8, 2023SOU EXTENSION 1 FILED
Saturday, July 8, 2023SOU EXTENSION 1 GRANTED
Tuesday, July 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 12, 2023SOU EXTENSION 2 FILED
Tuesday, December 12, 2023SOU EXTENSION 2 GRANTED
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 18, 2024SOU EXTENSION 3 GRANTED
Thursday, July 18, 2024SOU EXTENSION 3 FILED
Thursday, July 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 7, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, January 7, 2025TEAS STATEMENT OF USE RECEIVED